Pettit C, Trinidad J, Chung C, Patterson A, Kaffenberger BH. Hospital triage and skin disease: hospital outcomes are differentially associated with cutaneous morphology. Int J Dermatol. 2023;62(8):1034–9. https://doi.org/10.1111/ijd.16575.

Article  CAS  PubMed  Google Scholar 

Galimberti F, Guren L, Fernandez AP, Sood A. Dermatology consultations significantly contribute quality to care of hospitalized patients: a prospective study of dermatology inpatient consults at a tertiary care center. Int J Dermatol. 2016;55(10):e547–51. https://doi.org/10.1111/ijd.13327.

Article  PubMed  Google Scholar 

Korman AM, Alikhan A, Kaffenberger BH. Viral exanthems: an update on laboratory testing of the adult patient. J Am Acad Dermatol. 2017;76(3):538–50. https://doi.org/10.1016/j.jaad.2016.08.034.

Article  PubMed  Google Scholar 

Gallardo M, Gilkey T, Korman A, Chung C, Trinidad J, Kaffenberger BH. Drug eruptions are associated with increased length of stay in hospitalized patients with sepsis. Int J Dermatol. 2023;62(5):e319–20. https://doi.org/10.1111/ijd.16249.

Article  PubMed  Google Scholar 

Yan A et al. Impact of morbilliform drug eruptions on health-related quality of life: a qualitative analysis. The Ohio State University Wexner Medical Center, 2024.

Sastre J, Manso L, Sanchez-García S, Fernández-Nieto M. Medical and economic impact of misdiagnosis of drug hypersensitivity in hospitalized patients. J Allergy Clin Immunol. 2012;129(2):566–7. https://doi.org/10.1016/j.jaci.2011.09.028.

Article  PubMed  Google Scholar 

Hernández-Salazar A, Rosales SP, Rangel-Frausto S, Criollo E, Archer-Dubon C, Orozco-Topete R. Epidemiology of adverse cutaneous drug reactions. A prospective study in hospitalized patients. Arch Med Res. 2006;37(7):899–902. https://doi.org/10.1016/j.arcmed.2006.03.010.

Article  PubMed  Google Scholar 

Oh DAQ, Yeo YW, Choo KJL, Pang SM, Oh CC, Lee HY. Acute generalized exanthematous pustulosis: epidemiology, clinical course, and treatment outcomes of patients treated in an Asian academic medical center. JAAD Int. 2021;3:1–6. https://doi.org/10.1016/j.jdin.2020.12.004.

Article  PubMed  PubMed Central  Google Scholar 

Mehsas Z, et al. DRESS syndrome: a descriptive series of 63 cases. Our Dermatol Online. 2023;14(3):268–73.

Article  Google Scholar 

Wasuwanich P, So JM, Chakrala TS, Chen J, Motaparthi K. Epidemiology of Stevens-Johnson syndrome and toxic epidermal necrolysis in the United States and factors predictive of outcome. JAAD Int. 2023;13:17–25. https://doi.org/10.1016/j.jdin.2023.06.014.

Article  PubMed  PubMed Central  Google Scholar 

Bigby M. Rates of cutaneous reactions to drugs. Arch Dermatol. 2001;137(6):765–70.

CAS  PubMed  Google Scholar 

Hunziker T, Künzi UP, Braunschweig S, Zehnder D, Hoigné R. Comprehensive hospital drug monitoring (CHDM): adverse skin reactions, a 20-year survey. Allergy. 1997;52(4):388–93. https://doi.org/10.1111/j.1398-9995.1997.tb01017.x.

Article  CAS  PubMed  Google Scholar 

Lee HY, Tay LK, Thirumoorthy T, Pang SM. Cutaneous adverse drug reactions in hospitalised patients. Singapore Med J. 2010;51(10):767–74.

CAS  PubMed  Google Scholar 

Gilkey T, Trinidad J, Kovalchin C, Minta A, Rosenbach M, Kaffenberger BH. Defining drugs that are high-risk associations for drug reactions within the hospital setting. J Clin Aesthet Dermatol. 2022;15(6):59–64.

PubMed  PubMed Central  Google Scholar 

Hung SI, et al. HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. Proc Natl Acad Sci USA. 2005;102(11):4134–9. https://doi.org/10.1073/pnas.0409500102.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tangamornsuksan W, Chaiyakunapruk N, Somkrua R, Lohitnavy M, Tassaneeyakul W. Relationship between the HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis. JAMA Dermatol. 2013;149(9):1025–32. https://doi.org/10.1001/jamadermatol.2013.4114.

Article  CAS  PubMed  Google Scholar 

Li X, et al. HLA-B*1502 increases the risk of phenytoin or lamotrigine induced Stevens-Johnson syndrome/toxic epidermal necrolysis: evidence from a meta-analysis of nine case-control studies. Drug Res (Stuttg). 2015;65(2):107–11. https://doi.org/10.1055/s-0034-1375684.

Article  CAS  PubMed  Google Scholar 

Chen WT, et al. The function of HLA-B*13:01 involved in the pathomechanism of dapsone-induced severe cutaneous adverse reactions. J Invest Dermatol. 2018;138(7):1546–54. https://doi.org/10.1016/j.jid.2018.02.004.

Article  CAS  PubMed  Google Scholar 

van der Linden PD, van der Lei J, Vlug AE, Stricker BH. Skin reactions to antibacterial agents in general practice. J Clin Epidemiol. 1998;51(8):703–8. https://doi.org/10.1016/s0895-4356(98)00041-9.

Article  PubMed  Google Scholar 

Mokhtari F, Nikyar Z, Naeini BA, Esfahani AA, Rahmani S. Adverse cutaneous drug reactions: eight year assessment in hospitalized patients. J Res Med Sci. 2014;19(8):720–5.

PubMed  PubMed Central  Google Scholar 

Krispinsky AJ, Shedlofsky LB, Kaffenberger BH. The frequency of low-risk morbilliform drug eruptions observed in patients treated with different classes of antibiotics. Int J Dermatol. 2020;59(6):647–55. https://doi.org/10.1111/ijd.14703.

Article  CAS  PubMed  Google Scholar 

Stewart A, Lehloenya R, Boulle A, de Waal R, Maartens G, Cohen K. Severe antiretroviral-associated skin reactions in South African patients: a case series and case-control analysis. Pharmacoepidemiol Drug Saf. 2016;25(11):1313–9. https://doi.org/10.1002/pds.4067.

Article  PubMed  Google Scholar 

Singh S, et al. Assessment of histopathological features of maculopapular viral exanthem and drug-induced exanthem. J Cutan Pathol. 2017;44(12):1038–48. https://doi.org/10.1111/cup.13047.

Article  PubMed  Google Scholar 

Ernst M, Lundgren M, Evans MD, Miller D, Giubellino A. The mixed spongiotic and interface reaction pattern: a study of clinical and histopathologic findings. J Cutan Pathol. 2022;49(12):1051–9. https://doi.org/10.1111/cup.14306.

Article  PubMed  PubMed Central  Google Scholar 

Seitz CS, Rose C, Kerstan A, Trautmann A. Drug-induced exanthems: correlation of allergy testing with histologic diagnosis. J Am Acad Dermatol. 2013;69(5):721–8. https://doi.org/10.1016/j.jaad.2013.06.022.

Article  CAS  PubMed  Google Scholar 

Stern RS. Clinical practice. Exanthematous drug eruptions. N Engl J Med. 2012;366(26):2492–501. https://doi.org/10.1056/NEJMcp1104080.

Article  CAS  PubMed  Google Scholar 

Sassolas B, et al. ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson syndrome and toxic epidermal necrolysis: comparison with case-control analysis. Clin Pharmacol Ther. 2010;88(1):60–8. https://doi.org/10.1038/clpt.2009.252.

Article  CAS  PubMed  Google Scholar 

Hadavand MA, Kaffenberger B, Cartron AM, Trinidad JCL. Clinical presentation and management of atypical and recalcitrant acute generalized exanthematous pustulosis. J Am Acad Dermatol. 2022;87(3):632–9. https://doi.org/10.1016/j.jaad.2020.09.024.

Article  PubMed  Google Scholar 

Weiss M, et al. Acute generalized exanthematous pustulosis: clinico-biological profile and inducing drugs in 83 patients. J Eur Acad Dermatol Venereol. 2023;37(6):e776–8. https://doi.org/10.1111/jdv.18940.

Article  CAS  PubMed  Google Scholar 

Szatkowski J, Schwartz RA. Acute generalized exanthematous pustulosis (AGEP): a review and update. J Am Acad Dermatol. 2015;73(5):843–8. https://doi.org/10.1016/j.jaad.2015.07.017.

Article  PubMed  Google Scholar 

Creadore A, et al. Clinical characteristics, disease course, and outcomes of patients with acute generalized exanthematous pustulosis in the US. JAMA Dermatol. 2022;158(2):176–83. https://doi.org/10.1001/jamadermatol.2021.5390.

Article  PubMed  Google Scholar